Safety and Efficacy of Conivaptan for the Correction of Hyponatremia in Neurological Patients

NCT00684164 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Unable to complete a contract with the Sponsor

Conditions

Hyponatremia

Interventions

DRUG: Conivaptan
OTHER: D5

Sponsor

Columbia University

Collaborators

[object Object]